Greek NIS Spiolto ELLACTO
NCT03419962 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1360
Last updated 2020-04-27
Summary
Open-label observational study: including COPD patients receiving treatment with Spiolto® Respimat® for approximately 6 weeks, which is the average time between two medical consultations
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
- DRUG
-
MaxSpiolto® Respimat® 160 Characters...
as per the approved SmPC
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-19
- Primary Completion
- 2018-11-09
- Completion
- 2019-04-03
Countries
- Greece
Study Locations
More Related Trials
-
DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD)
NCT01868009 ·Status: COMPLETED ·Phase: PHASE3
-
Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects
NCT02586493 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT03478696 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Triple Therapy in COPD
NCT03724877 ·Status: COMPLETED
-
Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE)
NCT05114434 ·Status: UNKNOWN
-
A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination
NCT03858348 ·Status: COMPLETED
-
Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD
NCT02477397 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease
NCT04091360 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Effectiveness of Symbicort vs. Advair Among COPD Patients
NCT01921127 ·Status: COMPLETED
-
Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in Greece
NCT02187926 ·Status: COMPLETED
-
EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in Daily Clinical Practice, in Greece
NCT02978703 ·Status: COMPLETED
-
Symbicort in Chronic Obstruktive Pulmonary Disease
NCT00612976 ·Status: COMPLETED
-
Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation
NCT01431911 ·Status: COMPLETED
-
Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD
NCT00291408 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease
NCT00219622 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.
NCT00808288 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT03474081 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation
NCT02522299 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
NCT01313676 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT03478683 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Effectiveness of COPD Treatments
NCT03376295 ·Status: COMPLETED
-
Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00929708 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Inhaled Corticosteroids on Sputum Bacterial Load in COPD
NCT01213693 ·Status: COMPLETED ·Phase: NA
-
INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design
NCT03467425 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease
NCT01911364 ·Status: COMPLETED ·Phase: PHASE3